Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardiac Troponins in Kidney Disease
Author(s): Daniel Murphy , Debasish Banerjee Added: 3 months ago

Heart Failure
Obesity and CKD: The Dual Epidemic in Cardiovascular Health
Author(s): Christopher Henry Grant , Samira Bell Added: 1 month ago

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Nephrologist
Dr Areef Ishani is a Nephrologist and Director of the Primary and Specialty Care Service Line atMinneapolis VA Health Care System, Minneapolis, MN, US. His areas of expertise are chronic kidney disease, end-stage renal disease, high potassium level, small lymphocytic lymphoma, and kidney transplant. View more
Research Area(s) / Expertise: Job title: Nephrology and Hypertension Specialist
Dr Erika Jones is Associate Professor in the Division of Nephrology and Hypertension at the University of Cape Town and Groote Schuur Hospital in Cape Town, SA.Dr Jones interests areparticularly in hypertension, having done her PhDin this area.One of the aspects of hypertension that she is studying currently and which is of major concern to nephrologists in Cape Town, is the rising incidence of… View more
Research Area(s) / Expertise: Job title: Professor of Renal Medicine
Prof James Burton isHonorary Consultant Nephrologist and Professor of Renal Medicine and Associate Dean for Clinical Research at the University of Leicester, Leicester, UK. His principal research interests are the mechanisms underlying uraemic cardiovascular disease modification of cardiovascular risk in patients with end-stage renal disease and the identification and application of novel… View more
Renal Impact: Rivaroxaban Versus Vitamin K Antagonists in AF
Author(s): Phong Phan Dinh , Tri Huynh Quang Ho , Hung Manh Pham , et al Added: 1 year ago

Anticoagulation

Electrophysiology & Arrhythmia
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Staging of Heart Failure with Preserved Ejection Fraction
Author(s): Anastasia Shchendrygina , Ilya Giverts , Mariya Tokmakova , et al Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Author(s): Chim C Lang Added: 5 months ago
Prof Chim Lang discusses his upcoming special focus for ECR. The collection will include contributions from Dr Emily Morris, Dr John Wilding, Dr Samira Bell, Dr Bianca Rocca, and Dr Ramzi Ajjan, the collection explores the global burden of obesity, its impact on heart failure and kidney disease, and emerging therapeutic strategies—including the evolving role of GLP-1 receptor agonists. View more

Cardiovascular Renal Metabolic
Real-World Data for CV and Renal Outcomes in DKD
Author(s): David Wheeler Added: 6 months ago
ERA 2025 - Prof David Wheeler (University College London, London, UK) joins us to discuss outcomes from real-world data investigating cardiovascular and renal outcomes in patients with DKD.Interview Questions:1. How do real-world cardiovascular and renal outcomes compare to clinical trial results, and which data sources are giving us the best insights into DKD outcomes?2. What's the biggest gap… View more

Cardiovascular Renal Metabolic